BeiGene, Ltd.·4

Jun 7, 4:11 PM ET

su Jingshyh S 4

4 · BeiGene, Ltd. · Filed Jun 7, 2019

Insider Transaction Report

Form 4
Period: 2019-06-05
Transactions
  • Award

    Share Option (Right to Buy)

    2019-06-05+64,61064,610 total
    Exercise: $9.23Exp: 2029-06-04Ordinary Shares (64,610 underlying)
Footnotes (2)
  • [F1]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares.
  • [F2]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.

Documents

1 file
  • 4
    wf-form4_155993828045293.xmlPrimary

    FORM 4